Matches in Wikidata for { <http://www.wikidata.org/entity/Q59616705> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q59616705 description "article scientifique publié en 2014" @default.
- Q59616705 description "artículu científicu espublizáu n'ochobre de 2014" @default.
- Q59616705 description "im März 2015 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59616705 description "scientific article published on 20 October 2014" @default.
- Q59616705 description "wetenschappelijk artikel" @default.
- Q59616705 description "наукова стаття, опублікована в березні 2015" @default.
- Q59616705 name "Prediction of Late Distant Recurrence After 5 Years of Endocrine Treatment: A Combined Analysis of Patients From the Austrian Breast and Colorectal Cancer Study Group 8 and Arimidex, Tamoxifen Alone or in Combination Randomized Trials Using the PAM50" @default.
- Q59616705 name "Prediction of Late Distant Recurrence After 5 Years of Endocrine Treatment: A Combined Analysis of Patients From the Austrian Breast and Colorectal Cancer Study Group 8 and Arimidex, Tamoxifen Alone or in Combination Randomized Trials Using the PAM50" @default.
- Q59616705 type Item @default.
- Q59616705 label "Prediction of Late Distant Recurrence After 5 Years of Endocrine Treatment: A Combined Analysis of Patients From the Austrian Breast and Colorectal Cancer Study Group 8 and Arimidex, Tamoxifen Alone or in Combination Randomized Trials Using the PAM50" @default.
- Q59616705 label "Prediction of Late Distant Recurrence After 5 Years of Endocrine Treatment: A Combined Analysis of Patients From the Austrian Breast and Colorectal Cancer Study Group 8 and Arimidex, Tamoxifen Alone or in Combination Randomized Trials Using the PAM50" @default.
- Q59616705 prefLabel "Prediction of Late Distant Recurrence After 5 Years of Endocrine Treatment: A Combined Analysis of Patients From the Austrian Breast and Colorectal Cancer Study Group 8 and Arimidex, Tamoxifen Alone or in Combination Randomized Trials Using the PAM50" @default.
- Q59616705 prefLabel "Prediction of Late Distant Recurrence After 5 Years of Endocrine Treatment: A Combined Analysis of Patients From the Austrian Breast and Colorectal Cancer Study Group 8 and Arimidex, Tamoxifen Alone or in Combination Randomized Trials Using the PAM50" @default.
- Q59616705 P1433 Q59616705-BA25DDB2-C6BA-4C3D-B771-0BD60950277F @default.
- Q59616705 P1476 Q59616705-3CE11102-6CE5-453C-863A-2943BC218D61 @default.
- Q59616705 P2093 Q59616705-34336911-43EF-4025-A886-3F00B39C92E3 @default.
- Q59616705 P2093 Q59616705-4B8D1892-EB2F-4F68-B79C-F467DCFBB51A @default.
- Q59616705 P2093 Q59616705-57415DE1-F265-4FD1-81D1-85F00F010892 @default.
- Q59616705 P2093 Q59616705-594BC3F4-43B0-4ACE-8705-F9C603C5F155 @default.
- Q59616705 P2093 Q59616705-69CDF56D-10A9-44F5-97E3-7698347746FE @default.
- Q59616705 P2093 Q59616705-6E283BF1-943C-4507-B7EE-229B5560D501 @default.
- Q59616705 P2093 Q59616705-8333F633-E2BB-43EB-9206-3142AA6C2C7B @default.
- Q59616705 P2093 Q59616705-E3CBF689-E3BA-4933-A0BE-6B32FA4DA2E6 @default.
- Q59616705 P304 Q59616705-DE3B5F6B-DF32-4791-8871-ADF61A4CE28A @default.
- Q59616705 P31 Q59616705-CDB3E4AD-187C-4BF8-8CEB-66FA17E119C9 @default.
- Q59616705 P356 Q59616705-8A156315-B152-4863-B76E-BAE67FE9B9AA @default.
- Q59616705 P407 Q59616705-1832CB7A-BA66-45D9-8ECB-76EE32EC7720 @default.
- Q59616705 P433 Q59616705-327C643C-CDEB-4830-9AA1-AE19D9DB69AE @default.
- Q59616705 P478 Q59616705-D9DD4E22-DC08-4805-B08E-0D5E24855455 @default.
- Q59616705 P50 Q59616705-60CD2399-F420-4E23-808C-085F24F12A87 @default.
- Q59616705 P50 Q59616705-6C2D240D-1A94-4C86-A270-A63585AB0C01 @default.
- Q59616705 P50 Q59616705-FC0C9AB4-6C4E-4EB2-AD99-A3010769A325 @default.
- Q59616705 P577 Q59616705-B1B52BF8-6423-4E1A-8E6B-B76DA966FC96 @default.
- Q59616705 P698 Q59616705-BDDA4794-A7FC-41A3-92B4-356E68F7BFF2 @default.
- Q59616705 P921 Q59616705-200302F6-455B-4A85-ACA3-A678200067DC @default.
- Q59616705 P921 Q59616705-42A29813-AFD8-4607-BC84-5F96C1ECD771 @default.
- Q59616705 P921 Q59616705-778B28ED-ADF8-4F49-8E92-3317446BE497 @default.
- Q59616705 P921 Q59616705-CEDA31D9-9DA6-48C4-82B1-7384EFDAA992 @default.
- Q59616705 P356 JCO.2014.55.6894 @default.
- Q59616705 P698 25332252 @default.
- Q59616705 P1433 Q400292 @default.
- Q59616705 P1476 "Prediction of late distant recurrence after 5 years of endocrine treatment: a combined analysis of patients from the Austrian breast and colorectal cancer study group 8 and arimidex, tamoxifen alone or in combination randomized trials using the PAM50 risk of recurrence score" @default.
- Q59616705 P2093 "Carl Schaper" @default.
- Q59616705 P2093 "Christian Fesl" @default.
- Q59616705 P2093 "Ivana Sestak" @default.
- Q59616705 P2093 "John Wayne Cowens" @default.
- Q59616705 P2093 "Martin Filipits" @default.
- Q59616705 P2093 "Mitch Dowsett" @default.
- Q59616705 P2093 "Peter Dubsky" @default.
- Q59616705 P2093 "Sean Ferree" @default.
- Q59616705 P304 "916-922" @default.
- Q59616705 P31 Q13442814 @default.
- Q59616705 P356 "10.1200/JCO.2014.55.6894" @default.
- Q59616705 P407 Q1860 @default.
- Q59616705 P433 "8" @default.
- Q59616705 P478 "33" @default.
- Q59616705 P50 Q18025935 @default.
- Q59616705 P50 Q21005493 @default.
- Q59616705 P50 Q79297574 @default.
- Q59616705 P577 "2014-10-20T00:00:00Z" @default.
- Q59616705 P698 "25332252" @default.
- Q59616705 P921 Q188874 @default.
- Q59616705 P921 Q25493920 @default.
- Q59616705 P921 Q412178 @default.
- Q59616705 P921 Q419143 @default.